Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Brussel
Onward Medical NV
Nieuws
Onward Medical NV
ONWD
BRU
: ONWD
| ISIN: NL0015000HT4
3/07/2026
2,620 EUR
(+0,77%)
(+0,77%)
3/07/2026
Aandeel volgen
Aandeel gevolgd
Samenvatting
Adviezen
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
26 mei 2026 ·
ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones
· Persbericht
19 mei 2026 ·
ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026
· Persbericht
13 mei 2026 ·
ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
· Persbericht
20 april 2026 ·
ONWARD Medical Publishes Closing of Bookbuild Offering
· Persbericht
16 april 2026 ·
ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
· Persbericht
15 april 2026 ·
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million
· Persbericht
1 april 2026 ·
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
· Persbericht
31 maart 2026 ·
ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones
· Persbericht
23 maart 2026 ·
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
· Persbericht
4 februari 2026 ·
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
· Persbericht
23 januari 2026 ·
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
· Persbericht
22 januari 2026 ·
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
· Persbericht
24 november 2025 ·
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
· Persbericht
17 november 2025 ·
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
· Persbericht
28 oktober 2025 ·
ONWARD Medical Publishes Closing of Bookbuild Offering
· Persbericht
24 oktober 2025 ·
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
· Persbericht
22 oktober 2025 ·
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
· Persbericht
13 oktober 2025 ·
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
· Persbericht
8 oktober 2025 ·
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
· Persbericht
8 oktober 2025 ·
Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe